Prediction of response to anticancer immunotherapy using gene signatures

J Clin Oncol. 2013 Jul 1;31(19):2369-71. doi: 10.1200/JCO.2013.49.2157. Epub 2013 May 28.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Adjuvants, Immunologic / therapeutic use*
  • Antigens, Neoplasm / immunology*
  • Antigens, Neoplasm / therapeutic use*
  • Biomarkers, Tumor / immunology*
  • Cancer Vaccines / therapeutic use*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / immunology*
  • Female
  • Humans
  • Immunotherapy / methods*
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / immunology*
  • Male
  • Melanoma / drug therapy*
  • Melanoma / immunology*
  • Molecular Targeted Therapy / methods*
  • Neoplasm Proteins / immunology*
  • Neoplasm Proteins / therapeutic use*
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / immunology*
  • Transcriptome*
  • Vaccination / methods*

Substances

  • Adjuvants, Immunologic
  • Antigens, Neoplasm
  • Biomarkers, Tumor
  • Cancer Vaccines
  • MAGEA3 protein, human
  • Neoplasm Proteins